|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
|
|---|---|---|
| Revenue | ||
| Cost of revenue | ||
| Gross profit | ||
| Sales, general and administrative expenses | ||
| Research and development expenses | ||
| Impairment loss on intangible assets | ||
| Operating loss | ||
| Interest income | ||
| Other income | ||
| Other gains and losses | ||
| Loss before income tax | ||
| Income tax benefit | ||
| Loss for the year | ||
| Unrealized gain on valuation of financial assets at fair value through other comprehensive income | ||
| Income tax effect on components that will not be reclassified to profit and loss | ||
| Component of other comprehensive income (loss) that will not be reclassified to profit and loss | ||
| Exchange differences on translation of foreign operations | ||
| Components of other comprehensive income (loss) that will be reclassified to profit or loss | ||
| Other comprehensive loss, net of income tax | ||
| Total comprehensive loss for the year | ||
| Loss per share – basic (in Dollars per share) | ||
| Loss per share – diluted (in Dollars per share) | ||
| LOSS ATTRIBUTABLE TO: | ||
| Owners of the parent | ||
| Non-controlling interests | ||
| Profit (loss) | ||
| TOTAL COMPREHENSIVE LOSS ATTRIBUTABLE TO: | ||
| Owners of the parent | ||
| Non-controlling interests |
Loading...
